5-Heptenamide,7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3R)-3-hydroxy-4-phenoxy-1-buten-1-yl]-5-oxocyclopentyl]-N-(methylsulfonyl)-,(5Z)- cas no:60325-46-4

Name5-Heptenamide,7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3R)-3-hydroxy-4-phenoxy-1-buten-1-yl]-5-oxocyclopentyl]-N-(methylsulfonyl)-,(5Z)-
CAS60325-46-4
Synonyms5-Heptenamide,7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3R)-3-hydroxy-4-phenoxy-1-butenyl]-5-oxocyclopentyl]-N-(methylsulfonyl)-,(5Z)- (9CI); 5-Heptenamide,7-[3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl]-N-(methylsulfonyl)-,[1R-[1a(Z),2b(1E,3R*),3a]]-; CP 34089; Nalador; SHB 286; Sulprostone; ZK 57671
EINECS(EC#)262-173-0
Molecular FormulaC23H31 N O7 S
Molecular Weight465.55974

Appearancewhite to off-white solid
refractive index1.589
storage temp?20°C

Hazard T:Toxic
Risk R60;R36/37/38
Safety

Safety Information of Sulprostone (CAS NO.60325-46-4):
Hazard Codes: T?
Risk Statements: 60-36/37/38
R60:May impair fertility
R36/37/38:Irritating to eyes, respiratory system and skin
Safety Statements: 53-22-36/37-45
S53:Avoid exposure - obtain special instructions before use
S22:Do not breathe dust
S36/37:Wear suitable protective clothing and gloves
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
WGK Germany: 3
RTECS: MJ8810000
Human reproductive effects by intravenous, intramuscular, intraplacental, and intracervical routes: pregnancy termination. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of SO_x and NO_x.

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intraperitoneal	18mg/kg (18mg/kg)	?	Eksperimental'naya i Klinicheskaya Farmakologiya. Experimental and Clinical Pharmacology. Vol. 56(4), Pg. 37, 1993.
rabbit	LD50	intraperitoneal	3mg/kg (3mg/kg)	?	Eksperimental'naya i Klinicheskaya Farmakologiya. Experimental and Clinical Pharmacology. Vol. 56(4), Pg. 37, 1993.
rat	LD50	intraperitoneal	12mg/kg (12mg/kg)	?	Eksperimental'naya i Klinicheskaya Farmakologiya. Experimental and Clinical Pharmacology. Vol. 56(4), Pg. 37, 1993.